| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Revenue | $22.1M | -19.5% |
| Cost of Revenue | $9.3M | +7.0% |
| Gross Profit | $12.9M | -31.7% |
| R&D Expense | $11.0M | +46.2% |
| SG&A Expense | $5.0M | -15.9% |
| Operating Income | -$17.4M | -151.4% |
| Pre-tax Income | -$19.1M | -161.2% |
| Income Tax | $232K | +198.7% |
| Net Income | -$19.3M | -173.2% |
| EPS (Basic) | -$1.62 | -125.0% |
| EPS (Diluted) | -$1.62 | -125.0% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $840K | -74.5% |
| Accounts Receivable | $4.0M | -18.7% |
| Inventory | $1.9M | +26.9% |
| Current Assets | $8.1M | -27.0% |
| Total Assets | $12.3M | -38.4% |
| Current Liabilities | $20.9M | +51.8% |
| Total Liabilities | $26.0M | +59.3% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.3M | -103.7% |
| Capital Expenditures | $550K | -78.8% |
| Investing Cash Flow | -$2.0M | +59.5% |
| Financing Cash Flow | $11.0M | +146.3% |
| Free Cash Flow | -$11.9M | -45.6% |
| Stockholders' Equity |
| -$13.7M |
| -484.0% |